• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Back to Search Results
Model Number CDK-1413
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Heart Failure (2206)
Event Date 09/25/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).There was no device malfunction reported, device functioned as expected.The device was not returned for evaluation and no device history review was done as no lot number was provided.
 
Event Description
A patient had a convergent procedure on (b)(6) 2017 and was enrolled in the converge trial.On (b)(6) 2017, she presented to the er with worsening bilateral edema/weeping and pain for 2 days.The patient confirmed worsening sob over shorter distances but her bad knees restricted her mobility as well and her family reported that her "breathing sounds wet" over the last two days.A ct scan showed pleural effusion, pericardial effusion (but not >1cm and not consistent with tamponade physiology), and pericarditis.Repeat transthoracic echocardiogram performed on (b)(6) 2017 showed no tamponade but elevated rap, and a septal shudder with suspected some effusive constrictive physiology, about the same as (b)(6) 2017.On (b)(6) 2017 cardiology was consulted and the following diagnosis included acute pericarditis secondary to epicardial and endocardial ablation procedure, clinically associated heart failure most consistent with effusive constrictive pericarditis with peripheral edema presumably related to diastolic heart failure with some dyspnea, along with small pericardial effusion with probable fibrinous exudate, and left and right pleural effusion.The subjects conditions improved and on (b)(6) 2017 was discharged home.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Type of Device
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Manufacturer (Section D)
ATRICURE, INC.
7555 innovation way
mason OH 45040
Manufacturer (Section G)
ATRICURE, INC.
7555 innovation way
mason OH 45040
Manufacturer Contact
anupam bedi
MDR Report Key6965830
MDR Text Key89925357
Report Number3011706110-2017-00091
Device Sequence Number1
Product Code OCL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142084
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other Health Care Professional
Device Model NumberCDK-1413
Device Catalogue NumberCDK-1413
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/25/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age76 YR
Patient Weight110
-
-